Literature DB >> 9846028

Definitions of hot flashes in breast cancer survivors.

G Finck1, D L Barton, C L Loprinzi, S K Quella, J A Sloan.   

Abstract

Menopause is an expected event in a woman's life. Treatment for breast cancer can impact the onset of menopause and precipitate symptoms such as hot flashes. Yet this sequelae of events is not well measured, defined or assimilated into quality of life assessments for cancer survivors. Though not life threatening, hot flashes can greatly impact a woman's quality of life or functional ability. It is important for health care professionals to more fully understand the nature of the experience of hot flashes so as not to underestimate their disruptive potential. As part of a larger clinical trial to look at the effectiveness of vitamin E for hot flashes, breast cancer survivors kept a log of both the frequency and intensity of their hot flashes. These women then wrote descriptions to define the severity of those hot flashes. The purpose of this paper is to provide insight into the experience of hot flashes in breast cancer survivors and to describe the severity of hot flashes with narratives given by the women experiencing them.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846028     DOI: 10.1016/s0885-3924(98)00090-6

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  15 in total

1.  Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors.

Authors:  H Irene Su; Mary D Sammel; Erin Springer; Ellen W Freeman; Angela DeMichele; Jun J Mao
Journal:  Breast Cancer Res Treat       Date:  2010-02-25       Impact factor: 4.872

2.  Mechanisms of cutaneous vasodilation during the postmenopausal hot flash.

Authors:  David A Low; Kimberley A Hubing; Juan Del Coso; Craig G Crandall
Journal:  Menopause       Date:  2011-04       Impact factor: 2.953

Review 3.  Chemotherapy-induced ovarian failure: manifestations and management.

Authors:  Julian R Molina; Debra L Barton; Charles L Loprinzi
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Pilot evaluation of a stellate ganglion block for the treatment of hot flashes.

Authors:  Deirdre R Pachman; Debra Barton; Paul E Carns; Paul J Novotny; Sherry Wolf; Breanna Linquist; Sadhna Kohli; DeAnne R Smith; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2010-05-23       Impact factor: 3.603

5.  MODERATING EFFECT OF HYPNOTIZABILITY ON HYPNOSIS FOR HOT FLASHES IN BREAST CANCER SURVIVORS.

Authors:  Gary Elkins; William Fisher; Aimee Johnson; Joel Marcus; Jacqueline Dove; Michelle Perfect; Timothy Keith
Journal:  Contemp Hypn Integr Ther       Date:  2011-09-01

6.  Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis.

Authors:  Aditya Bardia; Paul Novotny; Jeff Sloan; Deb Barton; Charles Loprinzi
Journal:  Menopause       Date:  2009 May-Jun       Impact factor: 2.953

7.  Levetiracetam for the treatment of hot flashes: a phase II study.

Authors:  Susan Thompson; Aditya Bardia; Angelina Tan; Debra L Barton; Lisa Kottschade; Jeff A Sloan; Brad Christensen; DeAnne Smith; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2007-06-28       Impact factor: 3.603

8.  Cutaneous and hemodynamic responses during hot flashes in symptomatic postmenopausal women.

Authors:  David A Low; Scott L Davis; David M Keller; Manabu Shibasaki; Craig G Crandall
Journal:  Menopause       Date:  2008 Mar-Apr       Impact factor: 2.953

9.  Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women.

Authors:  David R Walega; Leah H Rubin; Suzanne Banuvar; Lee P Shulman; Pauline M Maki
Journal:  Menopause       Date:  2014-08       Impact factor: 2.953

10.  A randomised trial of the cool pad pillow topper versus standard care for sleep disturbance and hot flushes in women on endocrine therapy for breast cancer.

Authors:  R Marshall-McKenna; A Morrison; L Stirling; C Hutchison; A M Rice; C Hewitt; L Paul; M Rodger; I R Macpherson; E McCartney
Journal:  Support Care Cancer       Date:  2015-10-08       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.